USP9X mRNA expression predicts clinical outcome for esophageal squamous cell carcinoma treated with cisplatin-based therapy
ConclusionThese findings suggest that high USP9X mRNA expression predicts poor clinical efficacy and survival to cisplatin-based therapy in patients with advanced ESCC.
Source: Clinics and Research in Hepatology and Gastroenterology - Category: Gastroenterology Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Esophagus Cancer | Gastroenterology | Skin Cancer | Squamous Cell Carcinoma | Study